Clinical Trials
2 trialsNCT03643484 2024-02-21
IMFINZI Specific-Clinical Experience Investigation in Patients With NSCLC After Definitive Chemoradiation Therapy
AstraZeneca
Completed
NCT04632342 2020-11-17
Phase 2a Clinical Trial to Evaluate the Efficacy and Safety of HL301 on Radiation Pneumonitis in Non-small Cell Lung Cancer Patients
Hanlim Pharm. Co., Ltd.
Phase 2 Unknown